{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:34:06Z","timestamp":1769153646477,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the grant of the Jiaxing Natural Science Foundation","award":["2022AZ30003"],"award-info":[{"award-number":["2022AZ30003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pulmonary arterial hypertension is a common complication in patients with congenital heart disease. In the absence of early diagnosis and treatment, pediatric patients with PAH has a poor survival rate. Here, we explore serum biomarkers for distinguishing children with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) from CHD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Samples were analyzed by nuclear magnetic resonance spectroscopy-based metabolomics and 22 metabolites were further quantified by ultra-high-performance liquid chromatography\u2013tandem mass spectroscopy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Serum levels of betaine, choline, S-Adenosyl methionine (SAM), acetylcholine, xanthosine, guanosine, inosine and guanine were significantly altered between CHD and PAH-CHD. Logistic regression analysis showed that combination of serum SAM, guanine and N-terminal pro-brain natriuretic peptide (NT-proBNP), yielded the predictive accuracy of 157 cases was 92.70% with area under the curve of the receiver operating characteristic curve value of 0.9455.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We demonstrated that a panel of serum SAM, guanine and NT-proBNP is potential serum biomarkers for screening PAH-CHD from CHD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03171-5","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T16:06:21Z","timestamp":1680105981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics"],"prefix":"10.1186","volume":"23","author":[{"given":"Nan","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyue","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baogang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"issue":"2","key":"3171_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00246-019-02273-2","volume":"41","author":"H Amoozgar","year":"2020","unstructured":"Amoozgar H, Banafi P, Mohammadi H, Edraki MR, Mehdizadegan N, Ajami G, Borzouee M, Keshaarz K, Moradi P, Dehghani E. Management of Persistent Pulmonary Hypertension after correction of congenital heart defect with autologous marrow-derived mononuclear stem cell injection into the Pulmonary artery: a pilot study. Pediatr Cardiol. 2020;41(2):398\u2013406.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"3171_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccm.2020.11.005","volume":"42","author":"EB Rosenzweig","year":"2021","unstructured":"Rosenzweig EB, Krishnan U. Congenital heart Disease-Associated Pulmonary Hypertension. Clin Chest Med. 2021;42(1):9\u201318.","journal-title":"Clin Chest Med"},{"key":"3171_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/heartjnl-2015-309132","volume":"102","author":"G Hansmann","year":"2016","unstructured":"Hansmann G, Apitz C, Abdul-Khaliq H, Alastalo T-P, Beerbaum P, Bonnet D, Dubowy K-O, Gorenflo M, Hager A, Hilgendorff A, et al. Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart. 2016;102:86\u2013100.","journal-title":"Heart"},{"issue":"3","key":"3171_CR4","first-page":"fca","volume":"14","author":"P Emma","year":"2018","unstructured":"Emma P, Tulloh Robert MR. Pulmonary hypertension in congenital heart disease. Future Cardiol. 2018;14(3):fca\u20132017.","journal-title":"Future Cardiol"},{"issue":"2","key":"3171_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1148\/rg.2017160105","volume":"37","author":"SB Malik","year":"2017","unstructured":"Malik SB, Chen N, Parker RA III, Hsu JY. Transthoracic Echocardiography: Pitfalls and Limitations as delineated at Cardiac CT and MR Imaging(1). Radiographics. 2017;37(2):383\u2013406.","journal-title":"Radiographics"},{"issue":"3","key":"3171_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ijcard.2014.04.156","volume":"174","author":"G Giannakoulas","year":"2014","unstructured":"Giannakoulas G, Mouratoglou S-A, Gatzoulis MA, Karvounis H. Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. A systematic review. Int J Cardiol. 2014;174(3):618\u201323.","journal-title":"Int J Cardiol"},{"issue":"9","key":"3171_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/1440-1681.12796","volume":"44","author":"X-y Li","year":"2017","unstructured":"Li X-y, Zheng Y, Long Y, Zhang X, Zhang L, Tian D, Zhou D, Lv Q-z. Effect of iloprost on biomarkers in patients with congenital heart disease-pulmonary arterial hypertension. Clin Exp Pharmacol Physiol. 2017;44(9):914\u201323.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"3171_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jacc.2012.05.005","volume":"60","author":"S Piran","year":"2012","unstructured":"Piran S, Liu P, Morales A, Hershberger RE. Where Genome meets Phenome: Rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure. J Am Coll Cardiol. 2012;60(4):283\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3171_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nbt823","volume":"21","author":"J Allen","year":"2003","unstructured":"Allen J, Davey HM, Broadhurst D, Heald JK, Rowland JJ, Oliver SG, Kell DB. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat Biotechnol. 2003;21(6):692\u20136.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"3171_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrd1157","volume":"2","author":"JK Nicholson","year":"2003","unstructured":"Nicholson JK, Wilson ID. Understanding \u2018global\u2019 systems biology: Metabonomics and the continuum of metabolism. Nat Rev Drug Discovery. 2003;2(8):668\u201376.","journal-title":"Nat Rev Drug Discovery"},{"key":"3171_CR11","doi-asserted-by":"crossref","unstructured":"Guasch-Ferre M, Hu FB, Ruiz-Canela M, Bullo M, Toledo E, Wang DD, Corella D, Gomez-Gracia E, Fiol M, Estruch R et al. Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study. Journal of the American Heart Association 2017, 6(11).","DOI":"10.1161\/JAHA.117.006524"},{"issue":"10","key":"3171_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.117.029166","volume":"136","author":"BA Kappel","year":"2017","unstructured":"Kappel BA, Lehrke M, Schutt K, Artati A, Adamski J, Lebherz C, Marx N. Effect of Empagliflozin on the metabolic signature of patients with type 2 diabetes Mellitus and Cardiovascular Disease. Circulation. 2017;136(10):969\u201372.","journal-title":"Circulation"},{"key":"3171_CR13","doi-asserted-by":"crossref","unstructured":"Ruiz-Canela M, Hruby A, Clish CB, Liang L, Martinez-Gonzalez MA, Hu FB. Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review. Journal of the American Heart Association 2017, 6(10).","DOI":"10.1161\/JAHA.117.005705"},{"key":"3171_CR14","doi-asserted-by":"crossref","unstructured":"Yu M, Sun S, Yu J, Du F, Zhang S, Yang W, Xiao J, Xie B. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics. J Proteome Res 2018, 17(10):3517\u20133525.","DOI":"10.1021\/acs.jproteome.8b00466"},{"issue":"5","key":"3171_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1373\/clinchem.2012.199257","volume":"59","author":"P Yin","year":"2013","unstructured":"Yin P, Peter A, Franken H, Zhao X, Neukamm SS, Rosenbaum L, Lucio M, Zell A, Haering H-U, Xu G, et al. Preanalytical Aspects and Sample Quality Assessment in Metabolomics Studies of Human Blood. Clin Chem. 2013;59(5):833\u201345.","journal-title":"Clin Chem"},{"issue":"30","key":"3171_CR16","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1021\/jf501744d","volume":"62","author":"B Xie","year":"2014","unstructured":"Xie B, Liu A, Zhan X, Ye X, Wei J. Alteration of gut Bacteria and Metabolomes after Glucaro-1,4-lactone treatment contributes to the Prevention of Hypercholesterolemia. J Agric Food Chem. 2014;62(30):7444\u201351.","journal-title":"J Agric Food Chem"},{"issue":"9","key":"3171_CR17","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1164\/rccm.201209-1726OC","volume":"187","author":"B Mickiewicz","year":"2013","unstructured":"Mickiewicz B, Vogel HJ, Wong HR, Winston BW. Metabolomics as a Novel Approach for early diagnosis of Pediatric Septic Shock and its mortality. Am J Respir Crit Care Med. 2013;187(9):967\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"3171_CR18","doi-asserted-by":"crossref","unstructured":"Amathieu R, Triba MN, Nahon P, Bouchemal N, Kamoun W, Haouache H, Trinchet J-C, Savarin P, Le Moyec L, Dhonneur G. Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis. Plos One 2014, 9(2).","DOI":"10.1371\/journal.pone.0089230"},{"issue":"6","key":"3171_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1515\/cclm-2017-0858","volume":"56","author":"M Yu","year":"2018","unstructured":"Yu M, Xiang T, Wu X, Zhang S, Yang W, Zhang Y, Chen Q, Sun S, Xie B. Diagnosis of acute pediatric appendicitis from children with inflammatory diseases by combination of metabolic markers and inflammatory response variables. Clin Chem Lab Med. 2018;56(6):1001\u201310.","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"3171_CR20","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1039\/b820224a","volume":"5","author":"P Yin","year":"2009","unstructured":"Yin P, Wan D, Zhao C, Chen J, Zhao X, Wang W, Lu X, Yang S, Gu J, Xu G. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Mol Biosyst. 2009;5(8):868\u201376.","journal-title":"Mol Biosyst"},{"issue":"3","key":"3171_CR21","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1021\/pr2010082","volume":"11","author":"P Zheng","year":"2012","unstructured":"Zheng P, Gao HC, Li Q, Shao WH, Zhang ML, Cheng K, Yang DY, Fan SH, Chen L, Fang L, et al. Plasma metabonomics as a Novel Diagnostic Approach for Major Depressive Disorder. J Proteome Res. 2012;11(3):1741\u20138.","journal-title":"J Proteome Res"},{"key":"3171_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.4103\/0973-1296.165551","volume":"11","author":"B Mamtimin","year":"2015","unstructured":"Mamtimin B, Xia G, Mijit M, Hizbulla M, Kurbantay N, You L, Upur H. Metabolic differentiation and classification of abnormal Savda Munziq\u2019s pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics. Pharmacognosy Magazine. 2015;11:698\u2013706.","journal-title":"Pharmacognosy Magazine"},{"issue":"6","key":"3171_CR23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nprot.2011.319","volume":"6","author":"J Xia","year":"2011","unstructured":"Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc. 2011;6(6):743\u201360.","journal-title":"Nat Protoc"},{"key":"3171_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jbiomech.2018.02.018","volume":"72","author":"AM Baker","year":"2018","unstructured":"Baker AM, Hsu FC, Gayzik FS. A method to measure predictive ability of an injury risk curve using an observation-adjusted area under the receiver operating characteristic curve. J Biomech. 2018;72:23\u20138.","journal-title":"J Biomech"},{"issue":"2","key":"3171_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/aje\/154.2.174","volume":"154","author":"EF Schisterman","year":"2001","unstructured":"Schisterman EF, Faraggi D, Reiser B, Trevisan M. Statistical inference for the area under the receiver operating characteristic curve in the presence of random measurement error. Am J Epidemiol. 2001;154(2):174\u20139.","journal-title":"Am J Epidemiol"},{"issue":"7341","key":"3171_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung Y-M, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u2013U82.","journal-title":"Nature"},{"issue":"14","key":"3171_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","volume":"35","author":"Z Wang","year":"2014","unstructured":"Wang Z, Tang WHW, Buffa JA, Fu X, Britt EB, Koeth RA, Levison BS, Fan Y, Wu Y, Hazen SL. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur Heart J. 2014;35(14):904\u201310.","journal-title":"Eur Heart J"},{"issue":"5","key":"3171_CR28","doi-asserted-by":"publisher","first-page":"L884","DOI":"10.1152\/ajplung.00473.2020","volume":"319","author":"PJ Barnes","year":"2020","unstructured":"Barnes PJ. COPD 2020: new directions needed. Am J Physiology-Lung Cell Mol Physiol. 2020;319(5):L884\u20136.","journal-title":"Am J Physiology-Lung Cell Mol Physiol"},{"issue":"8","key":"3171_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.metabol.2013.01.024","volume":"62","author":"R Alsayed","year":"2013","unstructured":"Alsayed R, Al Quobaili F, Srour S, Geisel J, Obeid R. Elevated dimethylglycine in blood of children with congenital heart defects and their mothers. Metabolism-Clinical and Experimental. 2013;62(8):1074\u201380.","journal-title":"Metabolism-Clinical and Experimental"},{"issue":"6","key":"3171_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/01.CIR.71.6.1113","volume":"71","author":"A Edlund","year":"1985","unstructured":"Edlund A, Berglund B, van Dorne D, Kaijser L, Nowak J, Patrono C, Sollevi A, Wennmalm A. Coronary flow regulation in patients with ischemic heart disease: release of purines and prostacyclin and the effect of inhibitors of prostaglandin formation. Circulation. 1985;71(6):1113\u201320.","journal-title":"Circulation"},{"key":"3171_CR31","doi-asserted-by":"crossref","unstructured":"Rosin DL, Hall JP, Zheng SQ, Huang LP, Campos-Bilderback S, Sandoval R, Bree A, Beaumont K, Miller E, Larsen J et al. Human Recombinant Alkaline Phosphatase (Ilofotase Alfa) Protects Against Kidney Ischemia-Reperfusion Injury in Mice and Rats Through Adenosine Receptors. Frontiers in Medicine 2022,9.","DOI":"10.3389\/fmed.2022.931293"},{"key":"3171_CR32","doi-asserted-by":"crossref","unstructured":"Sheng W, Wang H, Ma X, Qian Y, Zhang P, Wu Y, Zheng F, Chen L, Huang G, Ma D. LINE-1 methylation status and its association with tetralogy of fallot in infants. Bmc Medical Genomics 2012, 5.","DOI":"10.1186\/1755-8794-5-20"},{"issue":"4","key":"3171_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","volume":"10","author":"PK Chiang","year":"1996","unstructured":"Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, McCann PP. S-adenosylmethionine and methylation. Faseb J. 1996;10(4):471\u201380.","journal-title":"Faseb J"},{"key":"3171_CR34","doi-asserted-by":"crossref","unstructured":"Kalhan, Satish C. One carbon metabolism in pregnancy: Impact on maternal, fetal and neonatal health. Molecular & Cellular Endocrinology 2016:48\u201360.","DOI":"10.1016\/j.mce.2016.06.006"},{"issue":"4","key":"3171_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1357-2725(99)00139-9","volume":"32","author":"SC Lu","year":"2000","unstructured":"Lu SC. S-Adenosylmethionine. Int J Biochem Cell Biol. 2000;32(4):391\u20135.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"3171_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00246-018-1811-1","volume":"39","author":"S Kayali","year":"2018","unstructured":"Kayali S, Ertugrul I, Yoldas T, Kaya O, Karademir S. Sensitive Cardiac Troponins: could they be new biomarkers in Pediatric Pulmonary Hypertension due to congenital heart disease? Pediatr Cardiol. 2018;39(4):1\u20138.","journal-title":"Pediatr Cardiol"},{"key":"3171_CR37","doi-asserted-by":"crossref","unstructured":"Li G, Li Y, Tan XQ, Jia P, Zhao J, Liu D, Wang T, Liu B. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease. Pediatric Cardiology 2017.","DOI":"10.1007\/s00246-017-1705-7"},{"issue":"4","key":"3171_CR38","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00246-015-1335-x","volume":"37","author":"G Li","year":"2016","unstructured":"Li G, Tang L, Jia P, Zhao J, Liu D, Liu B. Elevated plasma connective tissue growth factor levels in children with pulmonary arterial hypertension Associated with congenital heart disease. Pediatr Cardiol. 2016;37(4):714\u201321.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"3171_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12890-017-0521-4","volume":"17","author":"TM Berghaus","year":"2017","unstructured":"Berghaus TM, Kutsch J, Faul C, Von Scheidt W, Schwaiblmair M. The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study. BMC Pulm Med. 2017;17(1):167.","journal-title":"BMC Pulm Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03171-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03171-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03171-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T16:09:19Z","timestamp":1680106159000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03171-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03171-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"15 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was approved by The Ethics Committee of Jiangxi Children\u2019s Hospital (No.Jxsetyy-yxky-20200101). All methods were performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical conduct of research"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"167"}}